Polycystic ovary syndrome (PCOS) lacks the generally accepted diagnostic biomarkers and targeted therapy. Increasing evidence indicates that microRNAs (miRNAs) play a crucial role in PCOS. Hereby, we tested the functional implications of a novel miRNA (miR-423-3p) as a mediator in the progress of hyperandrogenic PCOS, as well as its potential as a new serum biomarker and therapeutic target for the PCOS. We found significantly decreased miR-423-3p levels in serum, granulosa cells (hGCs), and follicular fluid (FF) of PCOS patients (n = 40) compared to healthy controls (n = 30), and this decrease corroborated in PCOS-like mouse models. The receiver operating characteristic (ROC) curve analysis for circulating miR-423-3p indicated high diagnostic potential as a biomarker, with an area under the curve (AUC) of 82%. miR-423-3p influenced human granulosa cell (KGN) proliferation by directly targeting CTNNBIP1 modulated WNT signaling pathway. We further proved as mechanistic role that the elevated dihydrotestosterone (DHT) inhibited the expression of miR-423-3p via the activation of the androgen receptor, and the overexpression of miR-423-3p normalized the function of androgen-induced GCs. While we overexpressed miR-423-3p, it counteracted androgen-induced dysfunction in GCs. Antiandrogen treatment restored the reproductive phenotypes in letrozole-induced PCOS-like mice and regulated miR-423-3p expression and its downstream effects. Ovarian intrabursal injection of miR-423-3p antagomir in wildtype (WT) mice induced PCOS-like phenotypes, further underscoring its functional role. Our results demonstrated that miR-423-3p emerged as a novel mediator in hyperandrogenic PCOS progression and it holds promise as both a diagnostic biomarker and a therapeutic target.
Keywords: Biomarker; Mir-423-3p; Polycystic ovary syndrome; Proliferation.
© The Author(s) 2025. Published by Oxford University Press on behalf of the Society for the Study of Reproduction. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.